The Ziopharm Oncology Inc. (ZIOP) Posts Quarterly Earnings Results, Hits Expectations

Ziopharm Oncology Inc. (NASDAQ:ZIOP) issued its earnings results on Wednesday. The biotechnology company reported ($0.11) earnings per share …

The Ligand Pharmaceuticals Inc. (LGND) Upgrade to Hold by The Zacks Investment Research

Ligand’s Captisol formulation technology has resulted in partnerships with … The biotechnology company reported $0.62 earnings per share for the …

Charlottesville biotech firms rising to meet Zika challenges

Several biotechnology companies in the Charlottesville area are working to combat the Zika virus. The CvilleBioHub, a new biotech networking …

The BioCryst Pharmaceuticals Inc. (BCRX) Given Buy Rating at the HC Wainwright

BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings data on Monday, November 7th. The biotechnology company reported …

The BioCryst Pharmaceuticals Inc. (BCRX) Given Buy Rating at the FBR & Co

The brokerage currently has a $6.00 price target on the biotechnology company’s stock. BCRX has been the subject of a number of other reports.

The Conatus Pharmaceuticals’ (CNAT) “Buy” Rating Reiterate at the JMP Securities

The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.34) by $0.03.

Prana Biotechnology Ltd (NASDAQ:PRAN) Has An Impact Score Of 0

Prana Biotechnology Ltd (NASDAQ:PRAN) has been given a 0.31 daily sentiment score for articles scanned across the internet today. Alpha One also …

The Heron Therapeutics Inc. (HRTX) Stock Rating Reaffirm by the JMP Securities

The biotechnology company reported ($1.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.17) …

The Zacks Investment Research Lowered Galena Biopharma Inc. (GALE) to Hold

The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.06) by …

The BioCryst Pharmaceuticals Inc. (BCRX) Receives Consensus Rating of “Hold” from Brokerages

The biotechnology company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.04. The firm earned $4.80 million …

1 41 42 43 44 45 46